View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 21, 2021

Reify Health extends StudyTeam platform availability for clinical trials

Cloud-based solutions provider Reify Health has announced the availability of its patient enrollment performance management platform, StudyTeam, to clinical research sites in 100 countries across the globe.

Cloud-based solutions provider Reify Health has announced the availability of its patient enrollment performance management platform, StudyTeam, to clinical research sites in 100 countries across the globe.

Last year, the company has expanded StudyTeam availability to 88 new countries.

The latest milestone marks Reify Health’s investment in providing effective solutions to sites for the management of recruitment and enrollment and reducing the manual work historically required from sites during trials.

Reify Health CEO and co-founder Ralph Passarella said: “Once a protocol has been designed, research sites do the lion’s share of the work to bring a clinical trial to life.

“Developing solutions that empower research site staff to recruit and enroll patients more efficiently has been a large part of our mission for years.”

StudyTeam solves the problem of clinical research sites that typically spend hours managing recruitment and enrollment and duplicating work manually by giving a centralised platform to sites to manage patients across all trials and sponsors.

By connecting directly with research sponsors, the platform enables communication of critical enrollment information securely and in real-time.

Sites that use StudyTeam enrol more than 15% more patients per month and have also reported a substantial decrease in the time clinical research spent by coordinators in managing recruitment and enrolment for sponsor trials.

Globally, more than 2,700 research sites are using the platform for patient recruitment and enrolment management. They are connected with biopharma sponsors including Amgen, AstraZeneca, and Eli Lilly and Company for enabling sharing of critical information related to recruitment activity in real time.

Sites using StudyTeam reported that the platform serves as a simple user experience built around site workflows.

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU